Litigation

Litigation Finance Expert Max Doyle Tapped to Expand Funder Program at Consumer Attorney Marketing Group

by

Los Angeles, California – The Consumer Attorney Marketing Group (CAMG) has recently announced the appointment of Max Doyle, a seasoned expert in litigation finance, as its new Chief Strategy Officer. This strategic hire underscores the firm’s increasing focus on its funder program which already represents more than half of its business operations. As Chief Strategy Officer, Doyle is set to spearhead the expansion of CAMG’s initiatives aimed at directly collaborating with litigation funders. Funders, who invest in legal claims with potential for high financial returns, are now working more directly with marketing agencies like CAMG … Read more

Alex Parker Earns Prestigious Role on Leadership Development Committee in High-Profile Suboxone Litigation

by

EDWARDSVILLE, IL — Flint Cooper, a leading litigation firm, has proudly announced the appointment of Alex Parker to the Leadership Development Committee (LDC) for the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation. This prestigious selection by the United States District Court for the Northern District of Ohio, Eastern Division, highlights Parker’s growing influence in the realm of mass tort litigation and bolsters his reputation as a potential future leader in the field. The LDC, a crucial part of the court’s strategy, is designed to nurture less experienced attorneys, allowing them to work directly with the Plaintiffs’ … Read more

Weight-Loss Drug Makers Navigate U.S. Litigation Landscape: Lessons from the Past and Strategies for Future Defense

by

Washington, D.C. – Amid booming sales, manufacturers of GLP-1 weight-loss drugs face a new challenge: the potential for mass tort litigation similar to what has historically rocked other sectors of the American pharmaceutical industry. Industry experts suggest that drawing lessons from past litigations could be key to these manufacturers not just surviving but thriving in an increasingly litigious environment. GLP-1, or glucagon-like peptide-1 receptor agonists, have gained attention not only for their effectiveness in obesity management but also for potential side effects which could become the focal point of legal battles. Given the aggressive nature … Read more

Surge in Hernia Mesh Litigation: Nationwide Lawsuits Point to Severe Complications and Pending Settlements

by

Across the United States, thousands of individuals who have endured complications from defective hernia mesh implants are seeking justice through litigation. Lawyers in all 50 states are currently managing these lawsuits, concentrated in a series of multidistrict litigations (MDLs). These legal actions involve various products created by leading medical device companies including Ethicon, a subsidiary of Johnson & Johnson, C.R. Bard (now part of Beckton Dickinson), Covidien, and Atrium Medical Corp. The primary grievances in these legal cases relate to severe post-surgical complications that plaintiffs argue stemmed from inherent defects in the mesh products. Allegations … Read more